Amarin Corp. Plc (AMRN)
13.82
-0.27
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
13.82
0.00 (0.00%)
After-Hours: 19:56
Amarin Total Assets (Quarterly) : 624.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 624.36M |
| March 31, 2026 | 645.76M |
| December 31, 2025 | 670.78M |
| September 30, 2025 | 659.81M |
| June 30, 2025 | 670.13M |
| March 31, 2025 | 655.68M |
| December 31, 2024 | 685.35M |
| September 30, 2024 | 750.62M |
| June 30, 2024 | 799.86M |
| March 31, 2024 | 790.01M |
| December 31, 2023 | 831.68M |
| September 30, 2023 | 839.03M |
| June 30, 2023 | 860.02M |
| March 31, 2023 | 860.19M |
| December 31, 2022 | 886.18M |
| September 30, 2022 | 908.30M |
| June 30, 2022 | 973.24M |
| March 31, 2022 | 973.71M |
| December 31, 2021 | 1.068B |
| September 30, 2021 | 1.036B |
| June 30, 2021 | 1.045B |
| March 31, 2021 | 990.25M |
| December 31, 2020 | 966.02M |
| September 30, 2020 | 960.20M |
| June 30, 2020 | 914.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 925.67M |
| December 31, 2019 | 882.21M |
| September 30, 2019 | 866.94M |
| June 30, 2019 | 389.92M |
| March 31, 2019 | 372.24M |
| December 31, 2018 | 385.71M |
| September 30, 2018 | 210.29M |
| June 30, 2018 | 204.13M |
| March 31, 2018 | 215.71M |
| December 31, 2017 | 163.34M |
| September 30, 2017 | 166.61M |
| June 30, 2017 | 170.09M |
| March 31, 2017 | 175.37M |
| December 31, 2016 | 169.82M |
| September 30, 2016 | 194.07M |
| June 30, 2016 | 147.64M |
| March 31, 2016 | 152.71M |
| December 31, 2015 | 173.46M |
| September 30, 2015 | 182.42M |
| June 30, 2015 | 195.17M |
| March 31, 2015 | 215.34M |
| December 31, 2014 | 171.11M |
| September 30, 2014 | 180.88M |
| June 30, 2014 | 205.84M |
| March 31, 2014 | 220.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 5.359B |
| Cellectis SA | 267.36M |
| Alkermes Plc | 4.393B |
| Akari Therapeutics Plc | 38.62M |
| Liquidia Corp. | 521.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 180.75M |
| Shareholders Equity (Quarterly) | 443.62M |
| Debt to Equity Ratio | 0.0118 |
| Current Ratio | 3.671 |
| Net Debt Paydown Yield | 0.16% |